Pharmaceutical Technology: News, Analysis & Industry Insights

Features

Podcast: The impact of prediction markets on the clinical sector

Fenwick partners Chelsea Anderson and Noah Solowiejczyk outline how prediction markets will impact how biotechs operate.

Frankie Fattorini

News

Astellas and AI Proteins sign miniprotein therapeutics deal

Salong Debbarma

News

MSD’s Keytruda and Padcev combination receives EC approval

Salong Debbarma

News

FDA approves GSK’s Hibsago as first functional cure for hepatitis B

News

AbbVie races into F1 as pharma companies continue push into sport

News

FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease

News

Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics

News

MHRA revokes approval for Valneva’s Ixchiq due to safety frailties

Analysis

PremiumAnalyst Comment

Global systems unprepared for rising threat of invasive fungal infections

GlobalData Healthcare

Features

Women’s health landscape shifting, but systemic hurdles remain

Annabel Kartal Allen

PremiumAnalyst Comment

CPHI 2026: Finding the right CDMO partner in an age of consolidation

Dominic Tyer

Features

Podcast: Key takeaways from EASD 2026 on where GLP-1s are headed

Manasi Vaidya

Themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Surging demand for injectable therapies (led by GLP‑1s) is exposing a new constraint in drug delivery: not innovation, but the ability to industrialise and manufacture devices at scale.

More themes

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Gonorrhea: Market View, Current and Future Competitive Landscape

$3495.00

Ulcerative Colitis (UC): Epidemiology Report and Forecast to 2035

$9995.00

Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Venture Capital Investment Trends in Pharma - Q3 2026

$795.00

Alzheimer’s Disease in 68 Markets: Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

$17995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Astellas and AI Proteins sign miniprotein therapeutics deal

MSD’s Keytruda and Padcev combination receives EC approval

FDA approves GSK’s Hibsago as first functional cure for hepatitis B

AbbVie races into F1 as pharma companies continue push into sport

FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease

Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics

MHRA revokes approval for Valneva’s Ixchiq due to safety frailties

Global systems unprepared for rising threat of invasive fungal infections

Women’s health landscape shifting, but systemic hurdles remain

CPHI 2026: Finding the right CDMO partner in an age of consolidation

Podcast: Key takeaways from EASD 2026 on where GLP-1s are headed

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Gonorrhea: Market View, Current and Future Competitive Landscape

Ulcerative Colitis (UC): Epidemiology Report and Forecast to 2035

Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Venture Capital Investment Trends in Pharma - Q3 2026

Alzheimer’s Disease in 68 Markets: Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Gonorrhea: Market View, Current and Future Competitive Landscape

Ulcerative Colitis (UC): Epidemiology Report and Forecast to 2035

Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Venture Capital Investment Trends in Pharma - Q3 2026

Alzheimer’s Disease in 68 Markets: Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing